-
公开(公告)号:EP3733665A1
公开(公告)日:2020-11-04
申请号:EP18893819.5
申请日:2018-12-25
发明人: SHIKANAI Daisuke , ISHIGURO Noriko , OMORI Osamu
IPC分类号: C07D417/14 , A61K31/5395 , A61K31/549 , A61P19/08 , A61P43/00 , C07D417/06
摘要: A novel compound represented by the following general formula (1), or a salt thereof, which has a superior EP 4 receptor agonist activity, and a medicament containing the compound or a salt thereof as an active ingredient, which can be used for promotion of osteogenesis, therapeutic treatment and/or promotion of healing of fracture and the like.